FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2884164588> ?p ?o ?g. }

• W2884164588 abstract "The aim of the studyis to evaluate the efficacy of the fixed combination of beta adrenergic receptor blocking agents (β-AB) bisoprolol and dihydropyridine calcium channel inhibitor (CCI) amlodipine in patients with uncontrolled arterial hypertension (AH), stableischemic heart disease (IHD) and metabolic syndrome (MS) in actual clinical practice.Material and methods. The study enrolled 61 patients with uncontrolled AH, stable IHD and MS in the open prospective randomized study. The patients were randomized into 2 groups, using opaque and sealed envelopes. Patients in group 1 (n =30) had been receiving angiotensin-converting enzyme inhibitor (ACE inhibitor or ACE-i) - ramipril in dose of 10 mg/day (Hartil, Egis), fixed combination of bisoprolol and amlodipine (Concor AM, Takeda) in different doses. Patients in group 2 (control, n=31) should have been treated at the discretion of the doctor, necessarily the treatment should have included the free combination of ACE inhibitors, generic b-AB and dihydropyridine CCI. Initially, and after 12 weeks of treatment we conducted 24-hour ambulatory blood pressure monitoring (APBM) with the assessment of key indicators of 24-hour blood pressure monitoring results, the parameters of the blood vessel hardness and central blood pressure. The Statistical analyses of the results were carried out using the software package Statistica 6.1 (StatSoft Inc., United States).Results. After 12 weeks of therapy, the target level of BP was - 96,7% in the 1st group and 87,1% in the 2nd group of patients. The application of Concor AM was accompanied by significant improvements of the indicators of APBM and of the blood vessel hardness and central blood pressure characteristics. In addition, the usage of Concor AM provides the normalization of 24-hour ambulatory blood pressure monitoring results in 73% of patients. In the control group we determined the positive, but less significant changes in the indicators of APBM and rarer normalization of 24-hour ambulatory blood pressure monitoring results than in the group of patients, administrating Concor AM.Conclusion. In patients with AH, IHD and MS the administration of Concor AM is provided a significant antihypertensive and vasoprotective effects, which are more effective by the side of using free combination of β-AB and dihydropyridine CCI." @default.
• W2884164588 created "2018-08-03" @default.
• W2884164588 creator A5006368602 @default.
• W2884164588 creator A5013114085 @default.
• W2884164588 creator A5033331224 @default.
• W2884164588 creator A5048054463 @default.
• W2884164588 creator A5054950804 @default.
• W2884164588 creator A5068699278 @default.
• W2884164588 creator A5078594804 @default.
• W2884164588 creator A5090892571 @default.
• W2884164588 date "2015-01-01" @default.
• W2884164588 modified "2023-10-01" @default.
• W2884164588 title "The efficacy offixed combination of bisoprolol and amlodipine in patients with arterial hypertension, ischemic heart disease and metabolic syndrome" @default.
• W2884164588 doi "https://doi.org/10.26442/2075-082x_12.1.26-31" @default.
• W2884164588 hasPublicationYear "2015" @default.
• W2884164588 type Work @default.
• W2884164588 sameAs 2884164588 @default.
• W2884164588 citedByCount "0" @default.
• W2884164588 crossrefType "journal-article" @default.
• W2884164588 hasAuthorship W2884164588A5006368602 @default.
• W2884164588 hasAuthorship W2884164588A5013114085 @default.
• W2884164588 hasAuthorship W2884164588A5033331224 @default.
• W2884164588 hasAuthorship W2884164588A5048054463 @default.
• W2884164588 hasAuthorship W2884164588A5054950804 @default.
• W2884164588 hasAuthorship W2884164588A5068699278 @default.
• W2884164588 hasAuthorship W2884164588A5078594804 @default.
• W2884164588 hasAuthorship W2884164588A5090892571 @default.
• W2884164588 hasBestOaLocation W28841645881 @default.
• W2884164588 hasConcept C126322002 @default.
• W2884164588 hasConcept C164705383 @default.
• W2884164588 hasConcept C2779134260 @default.
• W2884164588 hasConcept C2779646130 @default.
• W2884164588 hasConcept C2779670145 @default.
• W2884164588 hasConcept C2780578515 @default.
• W2884164588 hasConcept C511355011 @default.
• W2884164588 hasConcept C71924100 @default.
• W2884164588 hasConcept C84393581 @default.
• W2884164588 hasConceptScore W2884164588C126322002 @default.
• W2884164588 hasConceptScore W2884164588C164705383 @default.
• W2884164588 hasConceptScore W2884164588C2779134260 @default.
• W2884164588 hasConceptScore W2884164588C2779646130 @default.
• W2884164588 hasConceptScore W2884164588C2779670145 @default.
• W2884164588 hasConceptScore W2884164588C2780578515 @default.
• W2884164588 hasConceptScore W2884164588C511355011 @default.
• W2884164588 hasConceptScore W2884164588C71924100 @default.
• W2884164588 hasConceptScore W2884164588C84393581 @default.
• W2884164588 hasIssue "1" @default.
• W2884164588 hasLocation W28841645881 @default.
• W2884164588 hasLocation W28841645882 @default.
• W2884164588 hasOpenAccess W2884164588 @default.
• W2884164588 hasPrimaryLocation W28841645881 @default.
• W2884164588 hasRelatedWork W1218695398 @default.
• W2884164588 hasRelatedWork W2107692037 @default.
• W2884164588 hasRelatedWork W2359374262 @default.
• W2884164588 hasRelatedWork W2368044974 @default.
• W2884164588 hasRelatedWork W2379055279 @default.
• W2884164588 hasRelatedWork W2472997169 @default.
• W2884164588 hasRelatedWork W4228998815 @default.
• W2884164588 hasRelatedWork W4256299600 @default.
• W2884164588 hasRelatedWork W4287702690 @default.
• W2884164588 hasRelatedWork W1578261618 @default.
• W2884164588 hasVolume "12" @default.
• W2884164588 isParatext "false" @default.
• W2884164588 isRetracted "false" @default.
• W2884164588 magId "2884164588" @default.
• W2884164588 workType "article" @default.